Home Cart 0 Sign in  

[ CAS No. 4947-89-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 4947-89-1
Chemical Structure| 4947-89-1
Structure of 4947-89-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4947-89-1 ]

Related Doc. of [ 4947-89-1 ]

Alternatived Products of [ 4947-89-1 ]

Product Details of [ 4947-89-1 ]

CAS No. :4947-89-1 MDL No. :MFCD00022165
Formula : C7H7ClN2S Boiling Point : -
Linear Structure Formula :- InChI Key :LSYZRUOXXOTVAV-UHFFFAOYSA-N
M.W : 186.66 Pubchem ID :2734794
Synonyms :

Calculated chemistry of [ 4947-89-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 0.0
Num. H-bond donors : 2.0
Molar Refractivity : 51.26
TPSA : 70.14 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.82
Log Po/w (XLOGP3) : 2.42
Log Po/w (WLOGP) : 1.8
Log Po/w (MLOGP) : 1.79
Log Po/w (SILICOS-IT) : 2.29
Consensus Log Po/w : 2.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.79
Solubility : 0.3 mg/ml ; 0.00161 mol/l
Class : Soluble
Log S (Ali) : -3.54
Solubility : 0.0544 mg/ml ; 0.000291 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.86
Solubility : 0.258 mg/ml ; 0.00138 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.61

Safety of [ 4947-89-1 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P264-P270-P301+P310+P330-P405-P501 UN#:2811
Hazard Statements:H300 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4947-89-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4947-89-1 ]
  • Downstream synthetic route of [ 4947-89-1 ]

[ 4947-89-1 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 4947-89-1 ]
  • [ 20358-00-3 ]
  • [ 20358-01-4 ]
YieldReaction ConditionsOperation in experiment
59% With benzyltrimethylazanium tribroman-2-uide In acetic acid at 20℃; for 14 h; Thiourea 14 (105 mg, 0.56 mmol) was dissolved in 10 ml acetic acid. Benzyltrimethylammonium tribromide (329 mg, 0.84 mmol) was added and the reaction was stirred at rt for 14h. Acetic acid was removed in vacuo and the residue redissolved in 15 ml DCM. 10 ml 0.5 n aqueous NaOH was added and the aqueous phase was extracted with DCM (2 x 15 ml). The combined organic layers were filtered through a phase separator and the solvent was removed in vacuo. The crude product was purified by flash column chromatography with pentane-ethyl acetate (12:5) as eluent to yield 15 (61 mg, 59percent) as a white solid: 1H NMR (500 MHz, CD3OD) 7.05 (dd, J=8.4, 2.0 Hz, 1H), 7.35 (d, 2.0 Hz, 1H), 7.53 (d, J=8.4 Hz, 1H); 13C NMR (125 MHz, CD3OD) 117.41, 121.45, 121.60, 129.37, 131.55, 153.24, 170.04MS (ESI): m/z 185 [M+H]+.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 14, p. 4839 - 4843
[2] Yakugaku Zasshi, 1957, vol. 77, p. 649,651[3] Chem.Abstr., 1957, p. 16435
  • 2
  • [ 4947-89-1 ]
  • [ 20358-00-3 ]
Reference: [1] Medicinal Chemistry Research, 2012, vol. 21, # 7, p. 1136 - 1148
[2] Farmaco, Edizione Scientifica, 1982, vol. 37, # 3, p. 205 - 212
[3] Acta Poloniae Pharmaceutica - Drug Research, 2009, vol. 66, # 4, p. 387 - 392
[4] Journal of Heterocyclic Chemistry, 2011, vol. 48, # 6, p. 1351 - 1355
[5] Chemical Biology and Drug Design, 2016, p. 354 - 362
  • 3
  • [ 4947-89-1 ]
  • [ 20358-00-3 ]
  • [ 20358-01-4 ]
YieldReaction ConditionsOperation in experiment
59% With benzyltrimethylazanium tribroman-2-uide In acetic acid at 20℃; for 14 h; Thiourea 14 (105 mg, 0.56 mmol) was dissolved in 10 ml acetic acid. Benzyltrimethylammonium tribromide (329 mg, 0.84 mmol) was added and the reaction was stirred at rt for 14h. Acetic acid was removed in vacuo and the residue redissolved in 15 ml DCM. 10 ml 0.5 n aqueous NaOH was added and the aqueous phase was extracted with DCM (2 x 15 ml). The combined organic layers were filtered through a phase separator and the solvent was removed in vacuo. The crude product was purified by flash column chromatography with pentane-ethyl acetate (12:5) as eluent to yield 15 (61 mg, 59percent) as a white solid: 1H NMR (500 MHz, CD3OD) 7.05 (dd, J=8.4, 2.0 Hz, 1H), 7.35 (d, 2.0 Hz, 1H), 7.53 (d, J=8.4 Hz, 1H); 13C NMR (125 MHz, CD3OD) 117.41, 121.45, 121.60, 129.37, 131.55, 153.24, 170.04MS (ESI): m/z 185 [M+H]+.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 14, p. 4839 - 4843
[2] Yakugaku Zasshi, 1957, vol. 77, p. 649,651[3] Chem.Abstr., 1957, p. 16435
  • 4
  • [ 4947-89-1 ]
  • [ 20358-01-4 ]
Reference: [1] Journal of the Chemical Society [Section] C: Organic, 1969, p. 268 - 272
  • 5
  • [ 4947-89-1 ]
  • [ 19952-47-7 ]
YieldReaction ConditionsOperation in experiment
79% at 60 - 80℃; for 2 h; Step A: To a solution of l-(3-chlorophenyl)thiourea (5.09 g, 27.2 mmol) in acetic acid (100 mL) was added bromine (1.82 mL, 35.4 mmol) dropwise at 60 °C. The mixture was heated at 80 °C for 2 h and the solvent was removed under reduced pressure. Diethyl ether was added to the mixture to produce a precipitate. The solid was collected and dried to give 4- chlorobenzo[d]thiazol-2-amine (5.7 g, 79percent). MS m/z 185.9 [M+H]+.
79% With bromine In acetic acid Step A:
To a solution of 1-(3-chlorophenyl)thiourea (5.09 g, 27.2 mmol) in acetic acid (100 mL) was added bromine (1.82 mL, 35.4 mmol) dropwise at 60° C.
The mixture was heated at 80° C. for 2 h and the solvent was removed under reduced pressure.
Diethyl ether was added to the mixture to produce a precipitate.
The solid was collected and dried to give 4-chlorobenzo[d]thiazol-2-amine (5.7 g, 79percent). MS m/z 185.9 [M+H]+.
Reference: [1] Patent: WO2013/101974, 2013, A1, . Location in patent: Paragraph 00586; 00587
[2] Patent: US9617268, 2017, B2, . Location in patent: Page/Page column 321; 322
  • 6
  • [ 4947-89-1 ]
  • [ 3622-30-8 ]
Reference: [1] Patent: WO2013/101974, 2013, A1,
[2] Patent: US9617268, 2017, B2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4947-89-1 ]

Aryls

Chemical Structure| 107707-33-5

[ 107707-33-5 ]

1-(3,5-Dichlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 3696-23-9

[ 3696-23-9 ]

1-(4-Chlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 19250-09-0

[ 19250-09-0 ]

1-(3,4-Dichlorophenyl)thiourea

Similarity: 0.95

Chemical Structure| 7392-67-8

[ 7392-67-8 ]

1-(4-Chlorophenyl)-3-phenylthiourea

Similarity: 0.94

Chemical Structure| 1220-00-4

[ 1220-00-4 ]

1,3-Bis(4-chlorophenyl)thiourea

Similarity: 0.94

Chlorides

Chemical Structure| 107707-33-5

[ 107707-33-5 ]

1-(3,5-Dichlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 3696-23-9

[ 3696-23-9 ]

1-(4-Chlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 19250-09-0

[ 19250-09-0 ]

1-(3,4-Dichlorophenyl)thiourea

Similarity: 0.95

Chemical Structure| 7392-67-8

[ 7392-67-8 ]

1-(4-Chlorophenyl)-3-phenylthiourea

Similarity: 0.94

Chemical Structure| 1220-00-4

[ 1220-00-4 ]

1,3-Bis(4-chlorophenyl)thiourea

Similarity: 0.94

Amides

Chemical Structure| 107707-33-5

[ 107707-33-5 ]

1-(3,5-Dichlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 3696-23-9

[ 3696-23-9 ]

1-(4-Chlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 19250-09-0

[ 19250-09-0 ]

1-(3,4-Dichlorophenyl)thiourea

Similarity: 0.95

Chemical Structure| 7392-67-8

[ 7392-67-8 ]

1-(4-Chlorophenyl)-3-phenylthiourea

Similarity: 0.94

Chemical Structure| 1220-00-4

[ 1220-00-4 ]

1,3-Bis(4-chlorophenyl)thiourea

Similarity: 0.94

Amines

Chemical Structure| 107707-33-5

[ 107707-33-5 ]

1-(3,5-Dichlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 3696-23-9

[ 3696-23-9 ]

1-(4-Chlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 19250-09-0

[ 19250-09-0 ]

1-(3,4-Dichlorophenyl)thiourea

Similarity: 0.95

Chemical Structure| 7392-67-8

[ 7392-67-8 ]

1-(4-Chlorophenyl)-3-phenylthiourea

Similarity: 0.94

Chemical Structure| 1220-00-4

[ 1220-00-4 ]

1,3-Bis(4-chlorophenyl)thiourea

Similarity: 0.94

Thioureas

Chemical Structure| 107707-33-5

[ 107707-33-5 ]

1-(3,5-Dichlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 3696-23-9

[ 3696-23-9 ]

1-(4-Chlorophenyl)thiourea

Similarity: 0.97

Chemical Structure| 19250-09-0

[ 19250-09-0 ]

1-(3,4-Dichlorophenyl)thiourea

Similarity: 0.95

Chemical Structure| 7392-67-8

[ 7392-67-8 ]

1-(4-Chlorophenyl)-3-phenylthiourea

Similarity: 0.94

Chemical Structure| 1220-00-4

[ 1220-00-4 ]

1,3-Bis(4-chlorophenyl)thiourea

Similarity: 0.94